Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 4, 2007, Pages 744-750

  Torgerson, Troy R ^a   Ochs, Hans D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

autoimmunity; enteropathy; FOXP3; Immune dysregulation; immunosuppressive therapy; IPEX like; polyendocrinopathy; regulatory T cells; scurfy mice; stem cell transplantation; transcription factor; X linked (IPEX)

Indexed keywords

AUTOANTIGEN; CYCLOSPORIN A; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ALPHA; METHOTREXATE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

BONE MARROW TRANSPLANTATION; CD25 T LYMPHOCYTE DEFICIENCY; CELL FUNCTION; CELL MATURATION; COMPETITIVE ABILITY; ENTEROPATHY; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IPEX SYNDROME; PHENOTYPE; POLYENDOCRINOPATHY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; WILD TYPE; X CHROMOSOME LINKED DISORDER;

FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL DISEASES; MUTATION; PHENOTYPE; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES, REGULATORY;

EID: 34948875308     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.044     Document Type: Review

References (81)

1. Sneller M.C., Dale J.K., and Straus S.E. Autoimmune lymphoproliferative syndrome. Curr Opin Rheumatol 15 (2003) 417-421
2. Halonen M E.P., Myhre A.G., Perheentupa J., Husebye E.S., Kampe O., Rorsman F., et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87 (2002) 2568-2574
3. Gambineri E., Torgerson T.R., and Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15 (2003) 430-435
4. Powell B.R., Buist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100 (1982) 731-737
5. Torgerson T.R., Linane A., Moes N., Anover S., Mateo V., Rieux-Laucat F., et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132 (2007) 1705-1717
6. Levy-Lahad E., and Wildin R.S. Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: further evidence for an X-linked lethal syndrome. J Pediatr 138 (2001) 577-580
7. Nieves D.S., Phipps R.P., Pollock S.J., Ochs H.D., Zhu Q., Scott G.A., et al. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 140 (2004) 466-472
8. Wildin R.S., Smyk-Pearson S., and Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39 (2002) 537-545
9. Kobayashi I., Imamura K., Yamada M., Okano M., Yara A., Ikema S., et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exp Immunol 111 (1998) 527-531
10. McGinness J.L., Bivens M.M., Greer K.E., Patterson J.W., and Saulsbury F.T. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 55 (2006) 143-148
11. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
12. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
13. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106 (2000) R75-R81
14. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
15. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35 (2005) 1681-1691
16. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103 (2006) 6659-6664
17. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19 (2007) 345-354
18. Pillai V., Ortega S.B., Wang C.K., and Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 123 (2007) 18-29
19. Wang J., Ioan-Facsinay A., van der Voort E.I., Huizinga T.W., and Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37 (2007) 129-138
20. Carlsson P., and Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 250 (2002) 1-23
21. Jonsson H., and Peng S.L. Forkhead transcription factors in immunology. Cell Mol Life Sci 62 (2005) 397-409
22. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276 (2001) 37672-37679
23. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 102 (2005) 5138-5143
24. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
25. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
26. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 (2007) 931-935
27. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177 (2006) 3133-3142
28. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
29. Khattri R., Kasprowicz D., Cox T., Mortrud M., Appleby M.W., Brunkow M.E., et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 167 (2001) 6312-6320
30. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5 (2007) e38
31. Baron U., Floess S., Wieczorek G., Baumann K., Grutzkau A., Dong J., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37 (2007) 2378-2389
32. Zhang L., Yi H., Xia X.P., and Zhao Y. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance. Autoimmunity 39 (2006) 269-276
33. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W.T., et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109 (2007) 4368-4375
34. So T., and Croft M. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J Immunol 179 (2007) 1427-1430
35. Vu M.D., Xiao X., Gao W., Degauque N., Chen M., Kroemer A., et al. OX40 costimulation turns off Foxp3+ TREGS. Blood (2007) Jun 15 [epub ahead of print]
36. Bacchetta R., Gambineri E., and Roncarlo M.G. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 120 (2007) 227-235
37. Randolph D.A., and Fathman C.G. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med 57 (2006) 381-402
38. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
39. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
40. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
41. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16 (2004) 1643-1656
42. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6 (2005) 331-337
43. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 (2003) 199-210
44. Zorn E., Kim H.T., Lee S.J., Floyd B.H., Litsa D., Arumugarajah S., et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106 (2005) 2903-2911
45. Wei W.Z., Morris G.P., and Kong Y.C. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53 (2004) 73-78
46. Loser K., Hansen W., Apelt J., Balkow S., Buer J., and Beissert S. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 12 (2005) 1294-1304
47. Marinaki S., Neumann I., Kalsch A.I., Grimminger P., Breedijk A., Birck R., et al. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 140 (2005) 181-191
48. Yu P., Gregg R.K., Bell J.J., Ellis J.S., Divekar R., Lee H.H., et al. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol 174 (2005) 6772-6780
49. Stock P., DeKruyff R.H., and Umetsu D.T. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 6 (2006) 12-16
50. Hadeiba H., and Locksley R.M. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J Immunol 170 (2003) 5502-5510
51. Karlsson M.R., Rugtveit J., and Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199 (2004) 1679-1688
52. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363 (2004) 608-615
53. Joetham A., Takeda K., Taube C., Miyahara N., Matsubara S., Koya T., et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol 178 (2007) 1433-1442
54. Dubois B., Chapat L., Goubier A., Papiernik M., Nicolas J.F., and Kaiserlian D. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102 (2003) 3295-3301
55. Hauet-Broere F., Unger W.W., Garssen J., Hoijer M.A., Kraal G., and Samsom J.N. Functional CD25- and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol 33 (2003) 2801-2810
56. Zhang X., Izikson L., Liu L., and Weiner H.L. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 167 (2001) 4245-4253
57. Karube K., Ohshima K., Tsuchiya T., Yamaguchi T., Kawano R., Suzumiya J., et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 126 (2004) 81-84
58. Viguier M., Lemaitre F., Verola O., Cho M.S., Gorochov G., Dubertret L., et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173 (2004) 1444-1453
59. Berger C.L., Tigelaar R., Cohen J., Mariwalla K., Trinh J., Wang N., et al. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105 (2005) 1640-1647
60. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., and Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65 (2005) 2457-2464
61. Unitt E., Rushbrook S.M., Marshall A., Davies S., Gibbs P., Morris L.S., et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41 (2005) 722-730
62. Beyer M., Kochanek M., Darabi K., Popov A., Jensen M., Endl E., et al. Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 106 (2005) 2018-2025
63. Sharma S., Yang S.C., Zhu L., Reckamp K., Gardner B., Baratelli F., et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res 65 (2005) 5211-5220
64. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129 (2007) 1275-1286
65. Bennett C.L., Brunkow M.E., Ramsdell F., O'Briant K.C., Zhu Q., Fuleihan R.L., et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome. Immunogenetics 53 (2001) 435-439
66. Ferguson P.J., Blanton S.H., Saulsbury F.T., McDuffie M.J., Lemahieu V., Gastier J.M., et al. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet 90 (2000) 390-397
67. Bindl L., Torgerson T., Perroni L., Youssef N., Ochs H.D., Goulet O., et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 147 (2005) 256-259
68. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., and Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177 (2006) 8338-8347
69. Coenen J.J., Koenen H.J., van Rijssen E., Kasran A., Boon L., Hilbrands L.B., et al. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4(+)CD25(+)FoxP3(+) T cells. Bone Marrow Transplant 39 (2007) 537-545
70. Mazzolari E., Forino C., Fontana M., D'Ippolito C., Lanfranchi A., Gambineri E., et al. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 35 (2005) 1033-1034
71. Rao A., Kamani N., Filipovich A., Lee S.M., Davies S.M., Dalal J., et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 109 (2007) 383-385
72. Lucas K.G., Ungar D., Comito M., Bayerl M., and Groh B. Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. Bone Marrow Transplant 39 (2007) 55-56
73. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94 (1997) 3168-3171
74. Roifman C.M. Human IL-2 receptor alpha chain deficiency. Pediatr Res 48 (2000) 6-11
75. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., and Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119 (2007) 482-487
76. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
77. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., and Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
78. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 116 (2006) 1713-1722
79. Bennett C.L., and Ochs H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 13 (2001) 533-538
80. Kobayashi I., Shiari R., Yamada M., Kawamura N., Okano M., Yara A., et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet 38 (2001) 874-876
81. Myers A.K., Perroni L., Costigan C., and Reardon W. Clinical and molecular findings in IPEX syndrome. Arch Dis Child 91 (2006) 63-64